pyrrolidine dithiocarbamate has been researched along with Vasculitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagl, S; Kranzhöfer, R; Kübler, W; Libby, P; Pfeiffer, CA; Schmidt, J | 1 |
Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Theuer, J | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Vasculitis
Article | Year |
---|---|
Angiotensin induces inflammatory activation of human vascular smooth muscle cells.
Topics: Angiotensin II; Arteriosclerosis; Cells, Cultured; Humans; Interleukin-6; Muscle, Smooth, Vascular; NF-kappa B; Peptidyl-Dipeptidase A; Pyrrolidines; Receptors, Angiotensin; RNA, Messenger; Thiocarbamates; Vasculitis | 1999 |
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Chemokine CCL2; Coronary Circulation; Coronary Disease; DNA; Gene Expression; Humans; Hypertension; Intercellular Adhesion Molecule-1; Kidney Diseases; Male; NF-kappa B; Nitric Oxide Synthase; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Thiocarbamates; Transcription Factor AP-1; Vasculitis | 2000 |